Scientists develop potential new drug treatment to tackle viruses

February 10, 2014, Diamond Light Source
Credit: Diamond Light Source

( —An international team of scientists have successfully developed a novel compound which early signs suggest might prevent a range of viruses from infecting humans.  Researchers from Oxford, Beijing, Leeds and Innsbruck collaborated on the new inhibitor.  It targets a group of viruses responsible for hand, foot and mouth disease, especially the EV71 virus. This viral group causes numerous epidemics in children, mainly in Asia, with roughly 10 million cases reported every year in China alone.  Symptoms are usually mild but in some cases the disease can prove fatal - the Chinese government reported over 900 deaths in 2010. The disease is currently untreatable and is a major global threat to public health.

This discovery, published in Nature Structural and Molecular Biology, may also have important implications for combating other diseases. Hand, foot and mouth disease is caused by several closely related , and the new compound is effective against all of these. In addition, other wide-spread viruses are quite closely related (they belong to the same enterovirus genus), including poliovirus and many of the viruses responsible for the common cold. 

Professor Dave Stuart, Director of the Division of Structural Biology (STRUBI) in the Nuffield Department of Medicine at the University of Oxford and Life Science Director at Diamond, who worked on the new inhibitor, explains: "By targeting a structural feature also found in related viruses, it should be possible to devise similar therapeutics to target them. Within the field, I am aware of one company that is already making progress in targeting the major . Our work is still at an early stage, but we are working with academic groups in China to take the inhibitor forward." 

The new drug treatment, which so far has been tested only in isolated cells, was created using cutting edge techniques. Structure-based drug design refers to drug treatments that are specifically designed to target the structure of a disease; it works in three stages. Firstly the pathogen's structure must be solved. Secondly, scientists must determine how that structure relates to the functioning of the pathogen. Finally, they can develop a means of interacting with that structure to disable the pathogen.

The structure of EV71 was first solved at Diamond Light Source, the UK's national synchrotron, less than 2 years ago, in 2012. After this, scientists used the giant microscope to determine how the virus changes shape to enter the host.  Enteroviruses are part of a larger family of viruses called picornaviruses. These viruses have an outer shell which, once inside a host cell, breaks apart releasing the viral RNA into the cell. The team have been able to discover a very potent molecule which disables the mechanism by which the viral shell breaks open, thus stopping the virus in its tracks by making it unable to infect the host.

The Anglo-Chinese collaboration used two of Diamond's beamlines, I03 and I24, to develop the new methodology. When they determined the in 2012, the team saw a small pocket inside the virus where a drug might fit. They have now developed a potential drug molecule that can sit inside this pocket, where it locks the virus rigid, preventing it breaking open and releasing its RNA.

This research is still in its early stages, and there is a considerable way to go before the drug treatment is available on the market.  It's also important to note that viruses evolve exceptionally fast, and it may be that EV71 mutates to overcome the inhibitor. However, the early signs are promising, and now that the methodology exists, scientists may be able to develop the inhibitor to become resistant to mutations. The speed with which this development has come about – in less than two years from the original discovery of the virus structure – demonstrates the vast potential of structure-based drug design, and the remarkable capabilities that are now at scientists' disposal in the fight against disease.

Explore further: Trick that aids viral infection is identified

More information: 'More-powerful virus inhibitors from structure-based analysis of HEV71 capsid-binding molecules' will be published in Nature Structural & Molecular Biology. DOI: 10.1038/nsmb.2769

Related Stories

Trick that aids viral infection is identified

January 30, 2014

Scientists have identified a way some viruses protect themselves from the immune system's efforts to stop infections, a finding that may make new approaches to treating viral infections possible.

Diamond sheds light on basic building blocks of life

February 17, 2013

The UK's national synchrotron facility, Diamond Light Source, is now the first and only place in Europe where pathogens requiring Containment Level 3 – including serious viruses such as those responsible for AIDS, Hepatitis ...

Architecture and viral disease

November 21, 2012

(—Viruses are just bits of DNA or RNA and proteins, but they have proved to be capable of immense destruction to human health. How have they achieved the ability to create such devastating diseases in organisms ...

New findings reveal protein structure in rubella virus

December 10, 2013

(Medical Xpress)—Researchers have determined the structure of the rubella virus capsid protein, which is central to the virus's ability to assemble into an infectious particle and to infect humans.

Recommended for you

Cells lacking nuclei struggle to move in 3-D environments

January 20, 2018

University of North Carolina Lineberger Comprehensive Cancer Center researchers have revealed new details of how the physical properties of the nucleus influence how cells can move around different environments - such as ...

Microbial communities demonstrate high turnover

January 19, 2018

When Mark Twain famously said "If you don't like the weather in New England, just wait a few minutes," he probably didn't anticipate MIT researchers would apply his remark to their microbial research. But a new study does ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

not rated yet Feb 10, 2014
The work in this article is a step in the direction of internal cell health via tailored viruside compounds/chemicals. Where should we go next?

Since the immune system has means to identify foreign invaders outside our cells and then devise means to destroy them, we have an opportunity to create a nano-machine which is really a self replicating DNA/RNA gene that lives in our cells and does this same job. Modelled on the device the cell uses to repair DNA, this device would circulate inside the cell looking for deviant DNA/RNA groups and either destroying them or directing the cell to apotheosis. A second nano-machine might be devised that repairs mitochondrial DNA. These might be devised as a virus that have surface chemical flags such that should two of them meet inside a cell, only one would survive. The flags would not operate outside the cells. These nano-machines should be trained external to the target organism using healthy cells from the target as the template.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.